- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 24th, 2007
Preserving organs and killing cancer cells with products that employ nanotechnology—the emerging science of manufacturing at the molecular level—were the hot topics last week when the New Jersey Technology Council sponsored a forum on one of the latest trends in biomedical research.
The Philadelphia gathering of 25 executives, scientists and other members of the health care community heard how nanotechnology is being used to make and develop biomedical devices and drugs. The science, which takes place on the scale of one billionth of a meter, is slowly leaving federally funded laboratories and making its way into fields ranging from retail to medicine.
Panelist Joseph Fischer, chairman and CEO of Lifeblood Medical Inc. in Adelphia, says his company employs nanotechnology to make Lifor, a liquid that preserves organs used for transplants, and to make LiforCell, which preserves tissues and cells used in laboratory experiments. He says the U.S. Navy is testing Lifor for limb preservation.
|Related News Press|
Scientists engineer tunable DNA for electronics applications June 21st, 2016
Marrying superconductors, lasers, and Bose-Einstein condensates: Chapman University Institute for Quantum Studies (IQS) member Yutaka Shikano, Ph.D., recently had research published in Scientific Reports June 20th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016